UBS O'Connor »

Vyne Therapeutics shares owned by UBS O'Connor

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-12-31 $823k 246k 3.35

More positions owned by UBS O'Connor

Spirit Aer Comcl (SPR)
Revance Th Note1 (Principal)
CRH Ord (CRH)
Peloton In Note2 (Principal)
Arch Resou Cla (ARCH)
NVIDIA Corporation (NVDA)
MercadoLibre (MELI)
Xpeng Ads (XPEV)
Parker-Hannifin Corporation (PH)
Nrg Energy Comne (NRG)
Fubotv Note3 (Principal)
Crown Holdings (CCK)
Flutter En SHS (FLUT)
Mattel (MAT)
Alibaba Gr Spons (BABA)

View all positions for UBS O'Connor

Top funds holding Vyne Therapeutics

Cormorant Asset Management
Eventide Asset Management
Citadel Advisors
Acorn Capital Advisors
Vanguard Group
Exome Asset Management
Palo Alto Investors
Adage Capital Partners GP
Patient Square Capital
UBS O'Connor
Schonfeld Strategic Advisors
Parkman Healthcare Partners
Springbok Capital Management
Geode Capital Management
Renaissance Technologies

View all funds holding Vyne Therapeutics